1h Free Analyst Time
The continuous renal replacement therapy devices market is forecasted to grow by USD 611.31 mn during 2023-2028, accelerating at a CAGR of 8.07% during the forecast period. The report on the continuous renal replacement therapy devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advantages of CRRT over IRRT, increase in incidence of acute kidney injury (AKI) and associated risk factors, and rapid increase in aging population.
The continuous renal replacement therapy devices market is segmented as below:
By Product
- Consumables
- Systems
By End-user
- Hospitals
- Dialysis centers
By Geographical Landscape
- Europe
- North America
- Asia
- Rest of World (ROW)
The report on the continuous renal replacement therapy devices market covers the following areas:
- Continuous renal replacement therapy devices market sizing
- Continuous renal replacement therapy devices market forecast
- Continuous renal replacement therapy devices market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global continuous renal replacement therapy devices market: Ardia Digital Health Ltd., Astellas Pharma Inc., B.Braun SE, Baxter International Inc., CytoSorbents Corp., DaVita Inc., DIAMED Medizintechnik GmbH, ECRI, Fresenius Medical Care AG and Co. KGaA, Infomed SA, Medica S.p.A., Medical Components Inc., Medtronic Plc, Nikkiso Co. Ltd., Nipro Medical Corp., SWS Hemodialysis Care Co. Ltd., Toray Industries Inc., Apollo Health and Lifestyle Ltd., Asahi Kasei Corp., and Medites Pharma spol. s.r.o..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is opportunities in emerging markets.'
According to the report, one of the major drivers for this market is the advantages of CRRT over IRRT.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Ardia Digital Health Ltd.
- Astellas Pharma Inc.
- B.Braun SE
- Baxter International Inc.
- CytoSorbents Corp.
- DaVita Inc.
- DIAMED Medizintechnik GmbH
- ECRI
- Fresenius Medical Care AG and Co. KGaA
- Infomed SA
- Medica S.p.A.
- Medical Components Inc.
- Medtronic Plc
- Nikkiso Co. Ltd.
- Nipro Medical Corp.
- SWS Hemodialysis Care Co. Ltd.
- Toray Industries Inc.
- Apollo Health and Lifestyle Ltd.
- Asahi Kasei Corp.
- Medites Pharma spol. s.r.o.